SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-16-000124
Filing Date
2016-08-08
Accepted
2016-08-08 16:07:24
Documents
34
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-20162q16.htm 10-Q 392746
2 EXHIBIT 31.1 exhibit3112q16.htm EX-31.1 14730
3 EXHIBIT 31.2 exhibit3122q16.htm EX-31.2 14665
4 EXHIBIT 32.1 exhibit3212q16.htm EX-32.1 12452
  Complete submission text file 0000920465-16-000124.txt   1866784

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ljpc-20160630.xml EX-101.INS 289531
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20160630.xsd EX-101.SCH 13839
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20160630_cal.xml EX-101.CAL 25280
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20160630_def.xml EX-101.DEF 78482
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20160630_lab.xml EX-101.LAB 221937
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20160630_pre.xml EX-101.PRE 129841
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 161814211
SIC: 2836 Biological Products, (No Diagnostic Substances)